APA (7th ed.) Citation

Y, X., Z, C., Z, L., C, Z., H, S., Z, L., . . . X, J. (2025). Live biotherapeutic enterococcus lactis MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles. Gut microbes, 17(1), 2557978. https://doi.org/10.1080/19490976.2025.2557978

Chicago Style (17th ed.) Citation

Y, Xian, et al. "Live Biotherapeutic Enterococcus Lactis MNC-168 Promotes the Efficacy of Immune Checkpoint Blockade in Cancer Therapy by Activating STING Pathway via Bacterial Membrane Vesicles." Gut Microbes 17, no. 1 (2025): 2557978. https://doi.org/10.1080/19490976.2025.2557978.

MLA (9th ed.) Citation

Y, Xian, et al. "Live Biotherapeutic Enterococcus Lactis MNC-168 Promotes the Efficacy of Immune Checkpoint Blockade in Cancer Therapy by Activating STING Pathway via Bacterial Membrane Vesicles." Gut Microbes, vol. 17, no. 1, 2025, p. 2557978, https://doi.org/10.1080/19490976.2025.2557978.